Leaderboard

En | De
Sie sind hier: Onkologie » Respirationstrakt 18. Januar 2026
Suchen
medline.ch
Respirationstrakt
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7784  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 155675  
   
Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancer.
J Transl Med
Cavaliere S, Fogolari M, Iuliani M, Foderaro S, Cortellini A, Simonetti S, Mingo EC, Calagna S, Russano M, Vincenzi B, Tonini G, Angeletti S, Pantano F.
PMID: 41547827 [PubMed - as supplied by publisher]


PM2.5-modulated targets and miRNAs associated with lung cancer and injury are protected by natural products.
Environ Pollut
Chuang YT, Yen CY, Liu W, Chang FR, Tsai YH, Chan WH, Chien TM, Chang HW.
PMID: 41547393 [PubMed - as supplied by publisher]


Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark.
Eur J Cancer
Budolfsen T, Petersen RH, Møller LB, Brabrand J, Saghir Z, Quist M.
PMID: 41547178 [PubMed - as supplied by publisher]


Corrigendum to "Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial" [Radiother. Oncol. 208 (2025) 110907].
Radiother Oncol
Dejonckheere CS, Nour Y, Sahlmann J, Engelhart MT, Hammi A, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Waller C, Schmid S, Miederer M, Brose A, Binder H, König J, Rimner A, Grosu AL, Nestle U, Gkika E.
PMID: 41547133 [PubMed - as supplied by publisher]


Efficacy of levosalbutamol for lung cancer patients receiving postoperative sputum expectoration by high-frequency chest wall oscillation.
Pak J Pharm Sci
Wang Y, Leng H.
PMID: 41546583 [PubMed - indexed for MEDLINE]


Improving aerobic capacity in patients with advanced non-small cell lung cancer: study protocol of the 3-armed randomized controlled BREATH trial.
Trials
De Lazzari N, Wiesweg M, Götte M, Franco J, Mincu RI, Jäger J, Huessler EM, Kuklik N, Stang A, Totzeck M, Tewes M.
PMID: 41546104 [PubMed - as supplied by publisher]


Evaluating the efficacy and safety of antibody-drug conjugates in non-small cell lung cancer: a systematic review and meta-analysis.
BMC Cancer
Zhang L, Jia H, Niu B.
PMID: 41545863 [PubMed - as supplied by publisher]


Robotic-assisted thoracic surgery for resectable lung cancer: efficacy, safety and surgical approaches - an umbrella review of meta-analyses.
BMC Surg
Xu Y, Han Q, Wang C, Xu J, Li X, Zhang Q.
PMID: 41545856 [PubMed - as supplied by publisher]


Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
Signal Transduct Target Ther
Wang M, Liu W, Guo H, Long H, Yu B, Zhao G, Wu J, Yue D, Zhao X, Li C, Zhang L, Wang S, Zhang Q, Zhang Z, Wang C.
PMID: 41545337 [PubMed - indexed for MEDLINE]


Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.
J Immunother Cancer
Onieva JL, Pérez-Ruiz E, Figueroa-Ortiz LC, Jurado JM, Martínez B, Carlos Benítez J, Rueda-Domínguez A, Barragán I.
PMID: 41545302 [PubMed - indexed for MEDLINE]


Next-generation lung-cancer-on-a-chip: toward personalized therapy, AI, and CRISPR-driven models.
Drug Discov Today
Hossain NS, Tasnim N, Ferdoush J, Roy A, Saha SC, Saha A.
PMID: 41544897 [PubMed - as supplied by publisher]


Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy.
Int J Radiat Oncol Biol Phys
Zhai T, Toprani SM, Dillon-Martin M, Doyle PF, Kang H, Novack C, Liang L, Christiani DC, Kozono DE, Nagel ZD.
PMID: 41544677 [PubMed - as supplied by publisher]


Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
Lu S, Wang J, Yang N, Lv D, Chen L, Wu L, Li X, Sun L, Yu Y, Jin B, Yang L, Guo Y, Xu H, Yi T, Zeng A, Dong X, Chen J, Wang Z, Niu H, Cheng Y, Pan P, Deng P, Pan H, Min X, Bai J, Liu L, Zhang T, Li J, Fan S, Shi MM, Mok T, Su W, SACHI Study Group.
PMID: 41544643 [PubMed - as supplied by publisher]


Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib.
Clin Lung Cancer
Tomasini P, Juan-Vidal O, Califano R, Lin CC, Hulo P, Dooms C, Fang J, Blasco A, Kowalski D, Salinas J, Babu G, Mun TL, Bearz A, Surmont V, Baldotto C, Sharma R, Arrieta O, Stencel K, Card C, Zer A, Massarelli E, Fang B, Mashru S, Schuchard J, Sermon J, Diels J, Chu PL, Withelder M, Bauml JM, Shah S, Baig M, Felip E.
PMID: 41544603 [PubMed - as supplied by publisher]


Adaptive and migration-enhanced tree seed algorithm for multi-threshold CT image segmentation and lung cancer recognition.
PLoS One
Li C, Jiang J, Ma Z, Yu Z, Li H, Liu J, Li L, Yu Z.
PMID: 41544119 [PubMed - indexed for MEDLINE]


Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)

.

Oncol Rep
Ma H, Li L, Jiao C, Cheng Y, He J, Jiang C, Tong Q, Yi D, Zhang Y.
PMID: 41543165 [PubMed - indexed for MEDLINE]


Letter to the Editor: Association Between Immunotherapy and Overall Survival in Malnourished Patients with Advanced Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan.
Nutr Cancer
Li N, Chen H, Wang Y, Li X.
PMID: 41542856 [PubMed - as supplied by publisher]


Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report.
Cancer Rep (Hoboken)
Nigi A, Kumasa T, Iwamoto K, Itani H, Kondou S, Uraki J.
PMID: 41542718 [PubMed - indexed for MEDLINE]


General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer.
J Liq Biopsy
Lo D, Wong J, Keenan R, Fingleton J, Wong ANM.
PMID: 41541744 [PubMed]


Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer.
iScience
Zhu L, Jia X, Xu L, Chen L, Fu X, Yan H, Ai B, Peng S.
PMID: 41541668 [PubMed]


   
   Artikel 1 - 20 / 155675    Seite 1 von 7784  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1